A narrative review on plasminogen activator inhibitor-1 and its (patho) physiological role: to target or not to target?

M Sillen, PJ Declerck - International journal of molecular sciences, 2021 - mdpi.com
Plasminogen activator inhibitor-1 (PAI-1) is the main physiological inhibitor of plasminogen
activators (PAs) and is therefore an important inhibitor of the plasminogen/plasmin system …

Adipocyte biology in breast cancer: From silent bystander to active facilitator

J Choi, YJ Cha, JS Koo - Progress in lipid research, 2018 - Elsevier
Adipocytes account for the largest proportion among the cells that comprise breast tissue;
therefore, they are considered to be a critical cell type in the tumor microenvironment of …

Plasminogen activator inhibitor‐1 (PAI‐1): a key factor linking fibrinolysis and age‐related subclinical and clinical conditions

M Cesari, M Pahor, RA Incalzi - Cardiovascular therapeutics, 2010 - Wiley Online Library
Introduction: The close relationship existing between aging and thrombosis has growingly
been studied in this last decade. The age‐related development of a prothrombotic …

COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness

F Du, B Liu, S Zhang - Journal of thrombosis and thrombolysis, 2021 - Springer
The novel coronavirus disease (COVID-19) has become a universally prevalent infectious
disease. The causative virus of COVID-19 is severe acute respiratory syndrome coronavirus …

Hepatic insulin resistance, metabolic syndrome and cardiovascular disease

R Meshkani, K Adeli - Clinical biochemistry, 2009 - Elsevier
BACKGROUND: The metabolic syndrome is a constellation of common metabolic disorders
that is associated with cardiovascular disease. Insulin resistance has a central role in the …

Therapeutics targeting the fibrinolytic system

H Lin, L Xu, S Yu, W Hong, M Huang… - Experimental & molecular …, 2020 - nature.com
The function of the fibrinolytic system was first identified to dissolve fibrin to maintain
vascular patency. Connections between the fibrinolytic system and many other physiological …

PAI-1 and the metabolic syndrome: links, causes, and consequences

MC Alessi, I Juhan-Vague - Arteriosclerosis, thrombosis, and …, 2006 - Am Heart Assoc
The link between plasminogen activator inhibitor (PAI)-1 and the metabolic syndrome with
obesity was established many years ago. Increased PAI-1 level can be now considered a …

The autocrine and paracrine roles of adipokines

K Karastergiou, V Mohamed-Ali - Molecular and cellular endocrinology, 2010 - Elsevier
Obesity, defined by an excess of adipose tissue, is often associated with the development of
various metabolic diseases. The increased and inappropriate deposition of this tissue …

The molecular mechanisms of intestinal inflammation and fibrosis in Crohn's disease

Y Hayashi, H Nakase - Frontiers in physiology, 2022 - frontiersin.org
Crohn's disease (CD) is an inflammatory bowel disease (IBD) with repeated remissions and
relapses. As the disease progresses, fibrosis and narrowing of the intestine occur, leading to …

Adipokines at the crossroad between obesity and cardiovascular disease

F Molica, S Morel, BR Kwak… - Thrombosis and …, 2015 - thieme-connect.com
Obesity, and especially excessive visceral adipose tissue accumulation, is considered as a
low-grade inflammatory state that is responsible for adipocyte dysfunction and associated …